As one of the oldest and most established venture capital firms in the US, Kleiner Perkins Caufield & Byers (KPCB), has had a helping hand in mainstreaming technologies from IT to biotech since its founding in 1972. While Kleiner Perkins hasn't yet invested in a bitcoin or blockchain company, it's likely it will soon do so via its newest fund, KPCB Edge. The seed-stage investment firm, announced 16th June and launched with a $4m budget, will have blockchain technology as one of its six core areas of focus. He said: "I see the bitcoin blockchain as an implementation of blockchain technology – so I'm interested in both the generalizable stack, as well as any specific implementations that see developer adoption."

http://www.coindesk.com/kleiner-perkins-blockchain-tech-aol-success-stories/?utm_content=buffer625fa&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer